Literature DB >> 18536956

Antisilicone antibodies are biologically unlikely.

Paal Klykken1, André Colas, Xavier Thomas.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18536956     DOI： 10.1007/s10067-008-0913-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  7 in total

1.  Aspecific immunoglobulin binding to hydrophobic surfaces.

Authors:  C J van Oss; J O Naim
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

2.  The adsorption of proteins on a polydimethylsiloxane elastomer (PEP) and their antigenic behavior.

Authors:  J E Butler; E P Lü; P Navarro; B Christiansen
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

3.  The non-specific binding of immunoglobulins to silicone implant materials: the lack of a detectable silicone specific antibody.

Authors:  K L White; P C Klykken
Journal:  Immunol Invest       Date:  1998 Jul-Sep       Impact factor: 3.657

4.  Determination of the immunoglobulin E postoperative variation as a measure of surgical injury.

Authors:  M Navarro-Zorraquino; R Lozano; J Deus; C Pastor; L Larrad; E Tejero; J Román; M J Palacios; J Torcal; J C Salinas
Journal:  World J Surg       Date:  2001-05       Impact factor: 3.352

5.  Antibodies to silicone elastomers and reactions to ventriculoperitoneal shunts.

Authors:  R M Goldblum; R P Pelley; A A O'Donell; D Pyron; J P Heggers
Journal:  Lancet       Date:  1992-08-29       Impact factor: 79.321

6.  The role of ethylene oxide allergy in sterile shunt malfunctions.

Authors:  T Pittman; D Williams; M Rathore; A P Knutsen; K R Mueller
Journal:  Br J Neurosurg       Date:  1994       Impact factor: 1.596

7.  The association between silicone implants and both antibodies and autoimmune diseases.

Authors:  Mehmet Bekerecioglu; Ahmet Mesut Onat; Mustafa Tercan; Hakan Buyukhatipoglu; Metin Karakok; Daghan Isik; Omer Bulut
Journal:  Clin Rheumatol       Date:  2007-07-04       Impact factor: 2.980
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.